Product Details

Zofran ODT (Tablet)

Ondansetron Hydrochloride
8 mg



DIN/PIN/NPN

02239373

Manufacturer

Sandoz Canada Inc.

Formulary Listing Date

2000-04-17  

Unit Price

NA

Amount MOH Pays

NA

Coverage Status

Not a Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

A04AA01

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02239373 Zofran ODT (Tablet) NA NA
02389991 Ondissolve ODF (Film) 4.9930 3.8840
02481731 Ondansetron ODT (Tablet) 4.9930 3.8840
02487349 Mint-Ondansetron ODT (Tablet) 4.9930 3.8840
02511290 Auro-Ondansetron ODT (Tablet) 4.9930 3.8840
02514974 Mar-Ondansetron ODT Tablet 4.9930 3.8840
02519240 Ondansetron ODT (Tablet) 4.9930 3.8840
02519453 PMS-Ondansetron ODT Tablet 4.9930 3.8840
02524287 Ondansetron ODT (Tablet) 4.9930 3.8840
02535327 Accel-Ondansetron ODT (Tablet) 3.8840 3.8840
02541378 Jamp Ondansetron ODF 4.9930 3.8840
 

LU Clinical Criteria

NO  

EAP Criteria

Therapeutic Class Reimbursement Criteria
Unclassified EAP Drugs

These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition

Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding.

Product Monograph

View Monograph